Biotechnology Venture Readiness Program 2025
A Virtual/Hybrid 9-week program - free for Saudi and Foreign biotech innovators at every stage
Top Startups BVRP'2025
Explore opportunities with top startups of the biotechnology venture readiness program 2025
Biotechnology Venture Readiness Program (BVPR’2025) – a 2.5-month intensive training and mentorship program, which started in October with 91 startups from 22 countries onboard, and ended in December, with the successful program completion and graduation of 62 startups building strong projects and having highly-qualified teams.
Program Included Advanced Knowledge & Practice
Explore global biotech trends and Saudi Arabia’s national strategy. Learn from success stories, infrastructure insights, and entry pathways that align with Vision 2030. Founders gain clarity on how to position their ventures within both global and local ecosystems
Assess your biotech venture’s scalability, regulatory alignment, and product development maturity. Includes readiness checklists, technical roadmapping, IP strategy development, and planning for clinical, manufacturing, and market access
Define your market opportunity through TAM/SAM/POSM analysis. Build stakeholder maps and early validation plans to strengthen credibility, refine product-market fit, and prepare for investor and partner engagement
Navigate SFDA and global regulatory pathways, design clinical trials, and understand HTA principles. Founders receive tools to align evidence generation with approval requirements, payer expectations, and long-term adoption strategies
Understand key IP types - patents, trade secrets, and proprietary data - and how to protect biotech innovation across Saudi, GCC, and global systems. Learn licensing models for joint development and commercialization. Includes a focused workshop on building IP defensibility and communicating it to investors
Master biotech financials - from investor-ready data rooms to valuation strategies that monetize IP and licensing. Explore funding instruments beyond equity, including SAFE, convertible notes, and venture debt. Learn how to align science, finance, and strategy in board decisions, and how to pivot deep-tech ventures into scalable, investor-attractive businesses
Craft compelling biotech branding and storytelling decks tailored for non-scientific audiences. Prepare investor materials, simulate pitch meetings, and refine your narrative - including how to communicate IP assets, exclusivity, and defensibility - to lead fundraising conversations with clarity and confidence
Identify core team roles, build scientific and strategic advisory boards, and prepare governance structures for accelerator onboarding. Includes founder selection criteria, mentorship access, and a final in-person forum in Riyadh to connect with ecosystem stakeholders, investors and showcase venture leadership
Unlock opportunities to pilot your technology with hospitals, research centers, and clinical partners. Gain visibility with ecosystem players and explore strategic collaborations that accelerate validation and adoption
Tap into a curated network of biotech investors, venture builders, and innovation platforms. Receive introductions, feedback, and matchmaking support to position your venture for funding and long-term growth
Startup Founders' Reviews
Biotechnology venture readiness program 2025
A heartfelt thank you to the Saudi Biotechnology Accelerator team, the mentors, speakers, and the entire organization for the support and for the warm welcome in Riyadh. It has been a privilege to share this space with leaders and innovators from so many countries. We truly believe in building stronger bridges between ecosystems, and we see Saudi Arabia as a strategic partner with a vision strongly aligned with health innovation. Looking forward to staying connected and moving forward together.
Truly an inspiring journey and a powerful program. I was honored to be part of the Biotechnology Venture Readiness Program and to contribute alongside such an exceptional ecosystem. Grateful to the Kingdom for its clear vision and long-term commitment to building a world-class biotechnology and deep-tech ecosystem. Thank you to the distinguished mentors and ecosystem leaders. Proud to contribute to this momentum as we shape the future of biotechnology together.
I would like to express my sincere appreciation to you and the entire Saudi Biotechnology Accelerator team for the valuable efforts, guidance, and knowledge you have provided throughout the program. It has been a truly enriching experience.
Honoured for VLEED to be part of this inspiring journey. This program didn’t just support us as a startup – it helped us sharpen our core mission: to build a Saudi-born, AI-powered biomarker engine that turns lab data into clear, actionable longevity insights for people in the Kingdom and beyond. Endless thanks to the incredible mentors, organizers, and ecosystem partners behind Program 2025. Your guidance, questions, and belief in our vision have pushed VLEED to a new level. This is just the beginning – together we can make Saudi Arabia a true global hub for biotech, healthspan, and preventive care.
Honored to have participated as the founder of RedSea BioCollagen. What started as a simple concept has transformed – thanks to the program and the guidance of incredible mentors – from a dream into a real vision now moving toward reality. Thank you all. What we learned in this month and a half came through a structured, guided, and well-designed curriculum delivered by some of the best in their fields. We gained knowledge across many areas, and now the real journey begins.
Being part of this program has been a real privilege for our startup. Meeting such inspiring mentors and lecturers has given us valuable insights and strengthened our vision. I’m truly grateful for all the guidance and support throughout this journey. The Kingdom’s drive in biotech and med-tech is creating powerful momentum, and we hope to continue contributing to this movement, including future opportunities to present our work on stage.
So honored and excited to participate in the Forum and grateful to all the amazing mentors and program organizers who generously shared their time and expertise. It is incredible to see such commitment to advancing biotechnology ventures and giving many lifesaving solutions more opportunities to succeed and thrive. After several weeks of content-rich sessions and insightful meetings with mentors, VuEssence is more ready than ever to meet the challenges ahead.
Thank you to all the mentors of the Saudi Biotech Accelerator for your guidance and valuable insights. Truly appreciate the time and expertise you share with us.
I’m proud to join the Saudi Biotechnology Accelerator Program as the innovator behind the first topical broad-spectrum antibiotic spray. Grateful for this opportunity and excited for the journey ahead.
Being part of the Biotechnology Accelerator has been a truly enriching experience. My sincere thanks to the programme team and all mentors for their valuable guidance and insightful sessions.
It has been an interesting and valuable journey to be part of the Biotechnology Accelerator. Thank you to the team delivering the programme and all of the mentors for their insightful sessions and contributions.
AIDAb Delighted to be part of the 2025 Saudi Biotechnology Accelerator cohort, a significant step forward in developing next-generation antibody therapeutics for unmet medical needs. Deep thanks to the exceptional mentors and the SBA team, whose guidance and support have been instrumental in shaping our progress and strengthening the Kingdom’s growing biotech landscape.
Amazing opportunity to be part of this accelerator.
A heartfelt thank you to all Mentors and the Saudi Biotech Accelerator team for your time, vision and encouragement. Being part of this journey with MetSanex has been an honour and an inspiration. Looking forward to building the next chapter together.
Thank you to all mentors, innovators, and partners for strengthening Saudi Arabia’s biotechnology ecosystem. Your support and achievements are truly appreciated.
As a founder, I’m truly grateful to have been part of this outstanding program. I gained immense value from the mentors, the sessions, and the community of innovators. Thank you for this transformative experience.
Grateful to be part of this inspiring journey with the Saudi Biotechnology Ventures Accelerator. Huge thanks to the incredible mentors for their guidance, support, and belief in us founders. The best is yet to come!
We are very happy to have been selected and to have successfully completed this amazing venture readiness program. Thank you, Saudi Biotechnology Accelerator. And all the amazing world-class mentors for your time and dedication to supporting Rosetta Omics.
We're incredibly excited to share a major achievement for Onoids! We have successfully completed the rigorous Saudi Biotechnology Accelerator 2025 and have been selected to present at the final International Biotechnology Achievement Forum! Our two-month journey through the intensive Venture Readiness Program was key in refining the strategy for our integrated precision oncology platform. A huge thank you to the program organizers at Saudi Biotechnology Accelerator for the invaluable support!
Thank you to the Saudi Biotechnology Accelerator team and all the mentors for the insightful talks, workshops, and Q&A sessions.
Grateful for an inspiring day with the BioAccelerator 2025 cohort. Proud of ConvEyXO’s Venture Readiness certification and honoured to be recognised as an “International Startup Top Performer”.
Thank you, Saudi Biotechnology Accelerator, for the kind recognition and warm support. It was truly an honor to present Speratum Biopharma, Inc. at the International Biotechnology Achievement Forum 2025 in Riyadh and to engage with such a distinguished group of scientific, regulatory, and investment leaders. We are deeply grateful to the organizers, the Biotechnology Venture Readiness Program committee, and the expert panel for their confidence in our mission to advance next-generation RNAi therapeutics for solid tumors. We look forward to building meaningful partnerships in the Kingdom.
Being part of this cohort of Saudi Biotechnology Accelerator has been a deeply inspiring experience. The energy, passion, and commitment within this accelerator remind us why meaningful innovation requires collaboration and shared purpose. We are sincerely grateful to the mentors and the organising team whose consistent support has helped us sharpen our direction and evolve with intention. Their investment in founders creates a space where growth feels possible and progress feels shared. Eco Terra remains motivated for what’s ahead. Saudi Arabia’s biotech momentum is real, and we’re proud to contribute our small part towards shaping a resilient, forward-looking ecosystem.
We value the opportunity to participate and appreciate the thoughtful guidance, insights, and conversations with the mentors and fellow participants throughout the program. We look forward to the next steps.
I had the honor of participating in the International Biotechnology Achievement Forum 2025 – Riyadh, an inspiring gathering of global leaders, researchers, and innovators shaping the future of biotechnology. As I continue advancing NanoHealix’s mission, I am eager to deepen partnerships in Saudi Arabia and remain open to opportunities that allow me to contribute more directly to the Kingdom’s thriving biotechnology ecosystem. Grateful to Saudi Biotechnology Accelerator for the chance to connect, learn, and envision new pathways for impact.
With deep respect and sincere appreciation, I thank the Saudi Biotechnology Accelerator, its leadership, and mentors for their trust, strategic stewardship, and long-term vision. This initiative stands apart through its clarity of direction, intellectual rigor, and sovereign-level ambition. It is more than an accelerator – it is a sovereign platform where future-defining solutions are shaped and the foundations of nationally significant ecosystems are built. It is an honor to be part of this vision. Thank you for the guidance, trust, and responsible leadership that is shaping the future.
We’re deeply grateful to the Saudi Biotechnology Accelerator for an inspiring journey through the Biotechnology Venture Readiness Program 2025. The program reflects Saudi Arabia’s strong ambition under Vision 2030 to build a globally relevant biotech ecosystem – one that encourages founders to think big, act boldly, and build responsibly. The experience sharpened our thinking around regulation, IP, clinical translation, and scalable manufacturing, while reinforcing the importance of affordability and access. Excited to be part of a growing biotech movement in the Kingdom.
PROGRAM ended on 14 december with a successful graduation of 62 startups from 22 countries
Led by Global Biotech Experts
Expert-Led. Founder-Focused. The Program is powered by top domain professionals. We’re proud to present our distinguished lecturers and mentors
Prof. Ahmed
Alaskar
Lecturer, Mentor (KSA)
MD, FRCP(C), FACP. Senior hematologist, professor, and biotech leader. Founded Saudi stem cell registry and oncology dept. Leads KAIMRC, driving national research, innovation, and biotech strategy across Saudi health ecosystem
Dr. Mobarak
Almulhim
Lecturer, Mentor (KSA)
MD, MBA. Senior Consultant in Critical Care & Emergency Medicine, Harvard faculty, and co-founder of Executive Health. Over 25 years in clinical, academic, and leadership roles across Saudi Arabia’s top health institutions
Dr. Abdallah A.
Adlan
Lecturer, Mentor (KSA)
Executive Director, Ethics & Compliance, Saudi NIH. Founder of Saudi NIH and the National Ethics Committee, with two PhDs and 25+ years shaping research governance. Led KAIMRC’s rise. Drives innovation in Saudi research ecosystem
Mr. Jeff
Stinson
Lecturer, Mentor (U.S.)
Founder and Director of HealthTech Arkansas, Jeff drives health innovation and startup growth in the medtech/healthtech. He’s led tech transfer, accelerator programs, and six venture funds over the past 20 years
Mr. Sultan
Almansour
Lecturer, Mentor (KSA)
CEO of All Care Group, a leading healthcare ecosystem in Saudi Arabia. With 20+ years across finance, healthcare, and manufacturing, he drives strategic localization, joint ventures, and innovation. All Care actively invests in biotech
Dr. Abdullah K.
Alshememry
Lecturer, Mentor (KSA)
Biotech strategist, advises Saudi health authorities on drug regulation, R&D, and healthcare policy. With leadership roles at SFDA, SCFHS, and King Saud University, drives innovation in regulation, and clinical research
Dr. George
Syrmalis
Lecturer, Mentor (U.S.)
MD, PhD. Founder of Bioscience Equity Partners, Dr. Syrmalis is a biotech investor and physician with global IPO success and deep expertise in nuclear medicine, theranostics, and translational research across the US, Europe, Saudi Arabia
Dr. Tariq
Tawfiq Massad
Lecturer, Mentor (Canada)
PhD, PMP. Biotech executive with 20+ years in biologics manufacturing, CMC strategy, and process development. VP at Eurofins CDMO, leading a $100M biomanufacturing expansion in North America. Formerly at IMV, Apotex, Sanofi
Dr. Jahad
Alghamdi
Lecturer, Mentor (KSA)
Executive Director of Benefit and Risk Evaluation at the Saudi Food and Drug Authority (SFDA). Oversees the scientific assessment of the clinical and non-clinical modules of medicinal products and leads regulatory decisions on clinical trial approvals
Dr. George
Voren
Lecturer, Mentor (U.S.)
Investor at Curie.Bio, focuses on global sourcing of new therapeutic companies. His work bridges science, business, and medicine. PhD in Neuropharmacology, contributed to the discovery of the first selective Orexin 1 Receptor Antagonist
Dr. Noha A.
Alotaibi
Lecturer, Mentor (KSA)
Biotechnology leader and Senior Chief of Experts at the Saudi Food and Drug Authority (SFDA). With 10+ years in biotechnology, healthcare, and strategy, she has played a key role in shaping national initiatives that advance Saudi biotechnology ecosystem
Mr. Fadzhairi
Jabar
Lecturer, Mentor (Malaysia)
Entrepreneur and biotech strategist, driving biotech investments and global partnerships, with 28 years of experience. CEO at Arcadia Life Sciences. Previously a GM at Intervenn San Francisco (US), and a VP at Malaysian Biotechnology Corporation
Dr. Ehab
AlShamleh
Lecturer, Mentor (Canada)
MSc, MTEI. Pharma executive and CMC strategist with 20+ years. Founder of CMC Strategy Partners, biotech ventures scale-up and compliance advisory. Held senior roles at Hikma and Baxter. Led 100+ products development and facility expansions (MENA, NA)
Dr. Matteo
Turi
Lecturer, Mentor (UK)
CFO, Mentor & Strategic Advisor. An accomplished Chief Financial Officer and entrepreneur with three decades of experience across biotechnology, clean energy, technology, etc. Structured multimillion-dollar investments
Dr. Ana
Baroni
Lecturer, Mentor (U.S.)
MD, PhD, and 6 MSc degrees with 25y+ of experience in Geromedicine, Regenerative, integrative, Functional, and Precision Medicine. Chief Science Officer at Longevitytech.fund. Expert in longevity, and due diligence
Dr. Sascha
Berger
Lecturer, Mentor (KSA)
Investment Director at NEOM Biotech, where he contributes to building Saudi Arabia’s emerging life sciences ecosystem. Brings 20 years of experience across life science venture capital, corporate M&A, strategy consulting, and family office advisory
Dr. Melya Hughes
Crameri
Lecturer, Mentor (UK, CH)
PhD, EPA, mIoD. 25+ yrs executive and strategic experience in the life sciences industry. Founded and served as CEO, CBO, at board level and as corporate development advisor to companies in Europe/USA. Managing Director at Awen Life Sciences
Mr. Salem
Almutairi
Lecturer, Mentor (KSA)
Intellectual Property Expert, Certified IP Trainer specializing in IP strategy, enforcement, and intangible asset management. Experienced in IP development and international collaboration, WIPO-certified, background in public administration and strategic management
Mr. Jalal
Awad
Lecturer, Mentor (Germany)
Global healthcare executive with over 20 years of cross-functional leadership across the MEA, Turkey, Europe, and Asia. Project Lead of Value Creation at Siemens Healthineers. Specialized in strategic consulting and investor support
Dr. Mariam
AlEissa
Mentor (KSA)
PhD, ACE. Certified Genetic consultant, with 20+ years in Saudi healthcare system, entrepreneur, Founder and CEO of Generation Health. Pioneers AI genomics, precision medicine, and cultural innovation across disciplines
Prof. Bander
Balkhi
Lecturer, Mentor (KSA)
Professor of Health Economics and Policy at the College of Pharmacy, King Saud
University. Focuses on key areas within health economics, including efficiency analysis, real world evidence, pharmaceutical pricing, and patient-reported outcomes (PROs)
Dr. Mustafa
Aljasser
Lecturer, Mentor (KSA)
B.Sc., MBA, an innovative professional, expert in the Pharmaceutical, Medical Devices, and Regulatory Sectors. Chief Business Officer at Sudair Pharmaceutical Company. Focuses on Oncology and Advanced Therapeutics
Dr. Yasser
Albogami
Lecturer, Mentor (KSA)
Academic leader and innovator at the intersection of artificial intelligence, real-world evidence (RWE), and health technology assessment (HTA). Vice Dean for Development and Associate Professor of Pharmaceutical Outcomes and Policy at King Saud University
Dr. Budoor
AlMansour
Lecturer, Mentor (KSA)
A biotech and healthcare entrepreneur with 17+ years in bridging science, business, and investment across Saudi Arabia, Australia, China, the UAE, and global markets. Co-founded Novo Genomics, advises on AI-driven precision health and biotech investments
Mr. Ali
Djedid
Lecturer, Mentor (France)
Head of Technical Scientific Solutions, EMEA at Merck Group (Life Science), with 12+ years leading technical operations, localization initiatives, and strategic partnerships across Europe and the Middle East. Directs multi-stakeholder programs in the pharma sector
Mr. Deepak
Mansukhani
Lecturer, Mentor (UAE)
Principal, Deals and Financial Institutions Advisory, MEA at IQVIA. 18 years as a Pharmaceutical industry practitioner and management consultant, worked for BCG, Accenture, and PwC, across the US, UK, EU, the MEA, India, and Mexico markets
Mr. Adel
Alghamdi
Lecturer, Mentor (KSA)
Regulatory affairs and GMP inspection expert with 6+ years of experience across biopharmaceutical industries. Specialized in biologics manufacturing, technology transfer, and localization strategies in line with Saudi Arabia’s Vision 2030
Eng. Hatim
Najjar
Lecturer, Mentor (KSA)
Biomedical Engineering Consultant, Executive Leader, Entrepreneur with 20+ years experience in healthcare. Founder & CEO of iDeal iDea and Founder of Saudi Med Access. Specializes in bridging biomedical innovation with commercialization
Dr. Yun Kyoung
Kang
Lecturer, Mentor (Korea)
An accomplished professional with 20+ years in research, spanning biochemistry, molecular biology, cell biology, and translational science, including drug discovery. Held significant leadership roles in the pharmaceutical industry and startup ventures
Mr. Osama K.
Bin Salman
Lecturer, Mentor (KSA)
MHA, SMP, BSMP, P3O, GRCP, IFCE. Executive leader and advisor in healthcare strategy, transformation, and growth. Co-founder and BoD Member for Health Entrepreneurship and other entities, enable startups in fundraising and market entry
Dr. Marwan
Alsaedi
Lecturer, Mentor (KSA)
Physician, entrepreneur, and biotech investor at the forefront of longevity, regenerative medicine, and aesthetic innovation. Dedicated to bridging science, clinical practice, and venture development
Dr. Amgad Talaat
Soliman
Lecturer, Mentor (KSA)
Global Healthcare and Biotechnology Executive, Strategic Alliances and Market Access Leader, Mentor. 30+ years experience 30+ years driving healthcare across the MEA. Regional Cluster Head for Saudi Arabia at EVA Pharma
Dr. Burhan
Fakhurji
Lecturer, Mentor (KSA)
Founder of iGene oncology & molecular genetics diagnostic lab, Founder of xGenome biotech company (KAUST) and founder of iGene Academy for virtual health innovation R&D (Jeddah). Virology and molecular researcher, visionary biotech leader
Mr. Zohaib
Ahmad
Lecturer, Mentor (KSA)
Seasoned entrepreneur and strategic advisor with deep expertise in Saudi market entry, information technologies, new venture establishment, and growth. Founder of Navigate Saudi and Co-Founder of NMKKN, actively contributing to the entrepreneurial ecosystems
Dr. Tanveer
Ahmad
Lecturer, Mentor (India)
Expert in advanced cell and gene therapies, CRISPR diagnostics and therapeutics, stem cell biology, mitochondrial metabolism, and AI-driven biomedical innovation. Integrates immunotherapy, molecular biology, computational tools
Galiya
Potapchuk
Program Manager (KSA)
Program founder, economist, Founder & CEO at Value Chain Global. Specializes in information and Saudi-focused investment and localization projects, global partnerships and delivering projects specific to executing Vision 2030 goals as a practice
Trusted By
Program Support & Partners, we’re proud to cooperate
Saudi Biotechnology Accelerator
Pioneering Riyadh-based Saudi Biotechnology Accelerator, advancing biotech, healthtech and life sciences innovators’ journey, and helping to excel in the markets, while actively contributing to the Saudi innovation ecosystem